As is shown in (Figure 5), the AD knowledge domain is currently dominated by speculations around APP (Amyloid beta (A4) precursor protein) and MAPT (Microtubule- associated protein tau) across all disease stages. This evidence concerns the gene APP and Alzheimer disease.